Home Infusion Options

What Home Infusion Options does

Home Infusion Options, Inc. (HIO) is a private, US-based home infusion therapy services provider headquartered in Chicago, operating on a national footprint. The company specializes in administering complex biologic and specialty medications to pediatric and adult patients managing chronic conditions across Gastroenterology, Rheumatology, Immunology, Neurology, Oncology, Pain Management, Dermatology, and Solid Organ Transplant. Its portfolio spans approximately 25+ injectable and infusible medications, including biologics (Remicade, Entyvio, Actemra, Stelara, Soliris), chemotherapy agents (Avastin, Keytruda, Velcade), IVIG, and transplant immunosuppressants.

The operating model is built around an in-house clinical and logistics stack rather than a software platform. Core operational capabilities include a dedicated care team per patient (Pharmacy Technician, Infusion Nurse, Billing Specialist), 24/7/365 nurse availability, in-house prior authorization management (up to 14 business days), co-pay assistance administration, and medication logistics via FedEx Priority Overnight delivery (2-3 days pre-visit). HIO holds ACHC (Accreditation Commission for Health Care) and PCAB (Pharmacy Compounding Accreditation Board) accreditations, providing regulatory standing required for reimbursement and hospital partnerships.

HIO operates a B2B2C go-to-market model. Revenue is generated through insurance reimbursement with co-pay assistance programs absorbing patient out-of-pocket costs (patients reportedly never receive a bill from HIO). The primary acquisition channel is referrals from specialist physicians (gastroenterologists, rheumatologists, neurologists, oncologists, transplant coordinators), supplemented by direct patient outreach via phone, fax, and online intake. Notable institutional relationships referenced in marketing materials include Northwestern Memorial Hospital and University of Chicago Pharmacy. The company is founder-led (Devin Barrett, CEO & Founder) with no disclosed outside funding or institutional ownership.

Name

Home Infusion Options

Legal name

Home Infusion Options, Inc.

Website

https://homeinfusionoptions.net

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Home Infusion Options is a private, US-based home infusion therapy provider administering complex biologic medications to pediatric and adult patients nationwide, managing insurance prior authorizations, 24/7 nursing, and medication logistics.

Ownership category

akta.pro rank

Product category

Home Infusion Therapy Services

NAICS

Home Health Care Services (6216)

SIC

Services-Home Health Care Services (8082)

akta.pro primary industry

Home Infusion Therapy & IV Nursing Services (HLADAFAG)

akta.pro secondary industries

Infusion & Home Infusion Pharmacy Services (HLAFALAG), IV Therapy, Infusion & Injection Services (Home-Based) (HSABACAF)

Keywords

• Home infusion therapy
• Specialty pharmacy services
• Biologic infusion administration
• Nursing infusion services
• Patient care coordination

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Home Infusion Therapy Services: Provides home-based administration of biologic medications including Actemra, Entyvio, IVIG, Remicade, Rituxan, Ocrevus, and others. Services include nursing care, medication delivery, and clinical monitoring. Revenue is generated through insurance reimbursement, with the company handling billing and prior authorizations directly.
2. Co-Pay Assistance Management: The company manages co-pay assistance programs on behalf of patients, submitting claims and coordinating with assistance programs to cover amounts insurance does not pay. Patients receive no bill from Home Infusion Options.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Home Infusion Options provides at-home infusion therapy services for pediatric and adult patients managing chronic conditions with complex biologic medications. The company coordinates nursing visits, medication delivery, insurance prior authorizations, and co-pay assistance across multiple medical specialties including Gastroenterology, Rheumatology, Immunology, Neurology, Oncology, Pain Management, Dermatology, and Solid Organ Transplant. It also operates a specialized College Connect program enabling college students to maintain treatment continuity on campus.

Product overview

Home Infusion Options (HIO) is a healthcare service company providing at-home infusion therapy for pediatric and adult patients. The core offering is home infusion services coordinated across multiple medical specialties including Gastroenterology, Rheumatology, Immunology, Neurology, Oncology, Pain Management, Dermatology, and Solid Organ Transplant. The company offers approximately 25+ injectable/infusible medications including biologics (Actemra, Entyvio, Remicade, Stelara, Soliris), chemotherapy agents (Avastin, Keytruda, Velcade), immunoglobulins (IVIG), and corticosteroids. Supporting services include insurance verification, prior authorization handling, co-pay assistance, nursing visits (24/7 availability), and medication delivery. A specialized College Connect program serves students managing chronic conditions while attending college.

Differentiator

Problem solved

Functional benefit

Brands

• College Connect: A program designed to help college students manage their chronic conditions and infusion therapy while attending higher education, providing seamless transition from home to campus care.

Products and services

• Home Infusion Therapy Services At-home infusion services for pediatric and adult patients managing chronic conditions with complex biologic infusions. Coordinates medication administration by company-employed nurses, insurance prior authorization, co-pay assistance, and FedEx Priority Overnight medication delivery.
• College Connect Program Specialized program for college students with chronic conditions requiring ongoing infusion therapy, supporting seamless transition from pediatric home-based care to campus-based adult care while maintaining treatment continuity.
• Insurance Verification and Authorization Services Handles insurance benefits verification, prior authorizations, and co-pay assistance program enrollment on behalf of patients, ensuring patients do not receive a bill from Home Infusion Options for covered services.
• Nursing Visit Services Registered nurses available 24/7/365 for home infusion administration, patient monitoring, and clinical support, with a consistent nurse assigned for every visit to ensure continuity of care.
• Medication Delivery Services Coordinates delivery of medications and supplies via FedEx Priority Overnight, arriving 2-3 days before scheduled infusion to ensure readiness for home administration.

Quantifiable outcome

• Nurses available 24/7, 365 days per year including evenings, weekends, and holidays
• +3 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Accreditation Commission for Health Care (ACHC)coreOthersACHC provides accreditation for home health and infusion services. Home Infusion Options displays the ACHC accreditation logo on their website, indicating compliance with industry standards for quality and safety in home-based healthcare delivery.
• Pharmacy Compounding Accreditation Board (PCAB)coreOthersPCAB accredits pharmacy compounding services. Home Infusion Options displays the PCAB accreditation logo, demonstrating compliance with quality standards for medication preparation, handling, and administration in home infusion settings.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• InfuSystem Holdings: Provider of infusion pumps and related home infusion services, with overlap in biologic delivery models and chronic-condition patient populations served.

Direct peers

• TwelveStone Health Partners: Specialty home infusion provider focused on chronic, complex patients with biologics and immunoglobulin therapy, with comparable hospital partnership and referral model.
• Paragon Healthcare: Specialty home infusion provider with national reach across immunoglobulin and biologic therapies — directly comparable patient population and chronic-condition focus.
• Vital Care Infusion Services: Franchise network of community-based home infusion pharmacies offering specialty biologics and chronic-condition therapies — comparable referral and clinical-nursing model to HIO.
• Amerita (PharMerica): Specialty home infusion pharmacy providing IVIG, biologics, and chronic disease therapies with a nursing-driven care model analogous to HIO's.
• KabaFusion: Specialty home infusion provider focused on IVIG, biologics, and complex chronic conditions, with a clinical nursing model very similar to HIO's dedicated-nurse approach.
• Soleo Health: Specialty home and alternate-site infusion provider delivering biologics, IVIG, and chronic disease therapies nationwide — comparable patient mix and provider referral-driven GTM motion.

Broad incumbents

• Coram (CVS Health): CVS Health-owned national home infusion provider delivering IV antibiotics, biologics, and specialty infusion therapies — directly comparable to HIO's home-based infusion and nursing model.
• Option Care Health: The largest independent provider of home and alternate-site infusion services in the U.S., serving patients across all 50 states with a broad specialty infusion portfolio directly overlapping HIO's core offering.
• Optum Infusion Services: UnitedHealth/Optum's home infusion arm offering nationwide specialty infusion and nursing services with deep payer integration — competes with HIO for the same biologic referral channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Home Infusion Options